198 related articles for article (PubMed ID: 32408979)
1. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
Chau KH; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
J Am Coll Cardiol; 2020 May; 75(19):2446-2458. PubMed ID: 32408979
[TBL] [Abstract][Full Text] [Related]
2. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
Oh JK; Lee SH; Lee SA; Kang DY; Lee S; Kim HJ; Ahn JM; Kim JB; Park DW; Song JM; Choo SJ; Kang DH; Song JK; Park SJ; Kim DH
Int J Cardiol; 2021 Jun; 332():60-66. PubMed ID: 33781852
[TBL] [Abstract][Full Text] [Related]
4. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.
Lindman BR; Stewart WJ; Pibarot P; Hahn RT; Otto CM; Xu K; Devereux RB; Weissman NJ; Enriquez-Sarano M; Szeto WY; Makkar R; Miller DC; Lerakis S; Kapadia S; Bowers B; Greason KL; McAndrew TC; Lei Y; Leon MB; Douglas PS
JACC Cardiovasc Interv; 2014 Jun; 7(6):662-73. PubMed ID: 24947722
[TBL] [Abstract][Full Text] [Related]
5. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
[TBL] [Abstract][Full Text] [Related]
6. Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
Rozenbaum Z; Finkelstein A; Zhitomirsky S; Topilsky Y; Halkin A; Banai S; Bazan S; Barbash I; Segev A; Guetta V; Danenberg H; Planner D; Orvin K; Assa HV; Assali A; Kornowski R; Steinvil A
Am Heart J; 2020 Feb; 220():184-191. PubMed ID: 31862472
[TBL] [Abstract][Full Text] [Related]
7. CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement.
Mooney J; Sellers SL; Blanke P; Pibarot P; Hahn RT; Dvir D; Douglas PS; Weissman NJ; Kodali SK; Thourani VH; Jilaihawi H; Khalique O; Smith CR; Kueh SH; Ohana M; Grover R; Naoum C; Crowley A; Jaber WA; Alu MC; Parvataneni R; Mack M; Webb JG; Leon MB; Leipsic JA
JACC Cardiovasc Interv; 2017 Aug; 10(15):1578-1587. PubMed ID: 28734891
[TBL] [Abstract][Full Text] [Related]
8. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement.
Ito N; Zen K; Takahara M; Tani R; Nakamura S; Fujimoto T; Takamatsu K; Yashige M; Kadoya Y; Yamano M; Yamano T; Nakamura T; Yaku H; Matoba S
ESC Heart Fail; 2023 Apr; 10(2):1336-1346. PubMed ID: 36725669
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Left Ventricular Diastolic Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement.
Asami M; Lanz J; Stortecky S; Räber L; Franzone A; Heg D; Hunziker L; Roost E; Siontis GC; Valgimigli M; Windecker S; Pilgrim T
JACC Cardiovasc Interv; 2018 Mar; 11(6):593-601. PubMed ID: 29501544
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement.
Pedersen ALD; Povlsen JA; Rasmussen VG; Frederiksen CA; Christiansen EH; Terkelsen CJ; Vase H; Poulsen SH
Int J Cardiovasc Imaging; 2023 Jan; 39(1):13-22. PubMed ID: 36598683
[TBL] [Abstract][Full Text] [Related]
12. Reversibility of Cardiac Function Predicts Outcome After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
Sato K; Kumar A; Jones BM; Mick SL; Krishnaswamy A; Grimm RA; Desai MY; Griffin BP; Rodriguez LL; Kapadia SR; Obuchowski NA; Popović ZB
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28698259
[TBL] [Abstract][Full Text] [Related]
13. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.
Alushi B; Beckhoff F; Leistner D; Franz M; Reinthaler M; Stähli BE; Morguet A; Figulla HR; Doenst T; Maisano F; Falk V; Landmesser U; Lauten A
JACC Cardiovasc Imaging; 2019 Apr; 12(4):591-601. PubMed ID: 29680341
[TBL] [Abstract][Full Text] [Related]
15. Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes.
Kolte D; Bhardwaj B; Lu M; Alu MC; Passeri JJ; Inglessis I; Vlahakes GJ; Garcia S; Cohen DJ; Lindman BR; Kodali S; Thourani VH; Daubert MA; Douglas PS; Jaber W; Pibarot P; Clavel MA; Palacios IF; Leon MB; Smith CR; Mack MJ; Elmariah S
JAMA Cardiol; 2022 Sep; 7(9):934-944. PubMed ID: 35895046
[TBL] [Abstract][Full Text] [Related]
16. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
[TBL] [Abstract][Full Text] [Related]
17. Women had favourable reverse left ventricle remodelling after TAVR.
Chen SC; Leu HB; Chang HH; Chen IM; Chen PL; Lin SM; Chen YH
Eur J Clin Invest; 2020 Jan; 50(1):e13183. PubMed ID: 31691961
[TBL] [Abstract][Full Text] [Related]
18. Blood Pressure and Arterial Load After Transcatheter Aortic Valve Replacement for Aortic Stenosis.
Lindman BR; Otto CM; Douglas PS; Hahn RT; Elmariah S; Weissman NJ; Stewart WJ; Ayele GM; Zhang F; Zajarias A; Maniar HS; Jilaihawi H; Blackstone E; Chinnakondepalli KM; Tuzcu EM; Leon MB; Pibarot P
Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28701528
[TBL] [Abstract][Full Text] [Related]
19. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
[TBL] [Abstract][Full Text] [Related]
20. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve.
Pibarot P; Hahn RT; Weissman NJ; Arsenault M; Beaudoin J; Bernier M; Dahou A; Khalique OK; Asch FM; Toubal O; Leipsic J; Blanke P; Zhang F; Parvataneni R; Alu M; Herrmann H; Makkar R; Mack M; Smalling R; Leon M; Thourani VH; Kodali S
JAMA Cardiol; 2017 Nov; 2(11):1208-1216. PubMed ID: 28973091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
